HF
CPXX

Hoxton Financial’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Hoxton Financial’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-47,970
Closed -$84K – 385
2015
Q4 		$84K Buy
+47,970
New +$82.2K 0.04% 104

Other funds holding CPXX

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hoxton Financial's CPXX Position: Q1 2016 in Review

Hoxton Financial sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q1 2016, closing a stake of 47,970 shares — an estimated $84K sold.

Hoxton Financial first reported a position in CPXX in Q4 2015 and held it in 1 quarter. The position peaked at $84K in Q4 2015. 58 funds tracked by Wall St. Rank hold CPXX as of Q1 2016.

  • Hoxton Financial reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Hoxton Financial sold 47,970 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q1 2016, an estimated $84K.
  • Hoxton Financial first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q4 2015 and held it in 1 quarter.
  • Hoxton Financial's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $84K in Q4 2015.
  • 58 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.